Rhabdomyolysis in connection with gastrointestinal disaese treatment – side effect or complication?

Rhabdomyolysis is a clinical biochemical syndrome, and has a multifactorial aethiology. The diagnosis of rhabdomyolysis relies on the elevation of creatine kinaese and on the presence of myolglobinuria. Our work examine the possible risk and role of specific gastrointestinal drug treatment as the concomittant infections during myopathy and rhabdomyolysis cases. Methods: drug monitoring databases, Cochrane and Pub Med databases as the source of metaanalysis. The evaluation of possible role of infectiouse states were only possible in index cases. Conclusion: proton pump inhibitors use may be associated with occure…